Market Closed -
Hong Kong S.E.
04:08:10 2024-05-21 am EDT
|
5-day change
|
1st Jan Change
|
6.96
HKD
|
-4.00%
|
|
+10.83%
|
-38.30%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,947
|
4,755
|
3,213
|
2,022
|
-
|
-
|
Enterprise Value (EV)
1 |
1,834
|
3,816
|
2,809
|
1,569
|
1,504
|
1,345
|
P/E ratio
|
-
|
66
x
|
205
x
|
23
x
|
16.1
x
|
12.9
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
9.7
x
|
12
x
|
6.78
x
|
3.56
x
|
2.89
x
|
2.36
x
|
EV / Revenue
|
6.04
x
|
9.65
x
|
5.93
x
|
2.76
x
|
2.15
x
|
1.57
x
|
EV / EBITDA
|
55.7
x
|
41.7
x
|
39.4
x
|
14.4
x
|
9.51
x
|
6.79
x
|
EV / FCF
|
-
|
-34,024,860
x
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-0%
|
-
|
-
|
-
|
-
|
Price to Book
|
2.44
x
|
3.73
x
|
2.38
x
|
1.41
x
|
1.29
x
|
1.18
x
|
Nbr of stocks (in thousands)
|
313,389
|
313,389
|
313,389
|
313,389
|
-
|
-
|
Reference price
2 |
9.403
|
15.17
|
10.25
|
6.452
|
6.452
|
6.452
|
Announcement Date
|
3/29/22
|
3/23/23
|
3/25/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
303.8
|
395.5
|
473.8
|
567.4
|
698.6
|
857.5
|
EBITDA
1 |
32.92
|
91.52
|
71.27
|
108.9
|
158.2
|
198.1
|
EBIT
1 |
20.52
|
72.08
|
25.01
|
76.6
|
125.7
|
165.5
|
Operating Margin
|
6.75%
|
18.22%
|
5.28%
|
13.5%
|
18%
|
19.3%
|
Earnings before Tax (EBT)
1 |
-
|
70.32
|
14.45
|
86.71
|
137.1
|
177.8
|
Net income
1 |
-
|
70.14
|
14.49
|
84.98
|
120.7
|
151.2
|
Net margin
|
-
|
17.73%
|
3.06%
|
14.98%
|
17.27%
|
17.63%
|
EPS
2 |
-
|
0.2300
|
0.0500
|
0.2800
|
0.4000
|
0.5000
|
Free Cash Flow
|
-
|
-112.2
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-28.36%
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/29/22
|
3/23/23
|
3/25/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
1,113
|
939
|
404
|
453
|
518
|
677
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-112
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-17.1%
|
5.65%
|
1.13%
|
6.35%
|
8.37%
|
9.58%
|
ROA (Net income/ Total Assets)
|
-
|
5.16%
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
1,359
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
3.850
|
4.070
|
4.310
|
4.590
|
4.990
|
5.490
|
Cash Flow per Share
|
-
|
-0.2300
|
-
|
-
|
-
|
-
|
Capex
|
-
|
43.4
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
10.97%
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/29/22
|
3/23/23
|
3/25/24
|
-
|
-
|
-
|
Last Close Price
6.452
CNY Average target price
9.773
CNY Spread / Average Target +51.47% Consensus |
1st Jan change
|
Capi.
|
---|
| -38.30% | 291M | | +72.98% | 12.38B | | -20.40% | 7.81B | | +6.24% | 6.72B | | +12.78% | 5.39B | | +38.73% | 5.03B | | -16.79% | 4.72B | | -22.01% | 4.06B | | -29.57% | 2.68B | | +52.38% | 2.59B |
Medical Equipment
|